Walder Wyss with CeQur on Series E equity financing

Walder Wyss advised CeQur, a Swiss medical device company specialising in insulin-delivery solutions, throughout closing of a USD 100 million Series E equity financing.

CeQur intends to use the funds to further accelerate growth across its commercial operations.

The Walder Wyss team

The Walder Wyss team was led by partner Patrick W. Vogel (corporate/M&A, pictured) and included partner André Kuhn (corporate/M&A and notarial services), senior associate Caroline Sauthier (corporate/M&A), associate Marina Srienz (corporate/M&A and notarial services) and managing associate Laurent Schmidt (corporate/M&A).